Income Before Tax
Pre-Tax Income
Neurocrine Biosciences Pre-Tax Income increased by 3.1% to $246.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1578.9%, from $14.70M to $246.80M. Over 3 years (FY 2022 to FY 2025), Pre-Tax Income shows an upward trend with a 48.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher values indicate stronger overall profitability and operational efficiency before tax impacts.
Detailed definition
Measures the profitability of the company after all operating and non-operating expenses have been deducted, but before...
Peer comparison
A standard GAAP metric used universally to compare pre-tax performance across different industries.
Metric ID:
income_before_taxHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.50M | $30.50M | $21.40M | -$23.30M | $97.90M | $117.90M | -$103.30M | $121.60M | $115.60M | $198.20M | $34.50M | $98.60M | $190.30M | $162.60M | $14.70M | $159.50M | $291.80M | $239.40M | $246.80M |
| QoQ Change | — | -47.0% | -29.8% | -208.9% | +520.2% | +20.4% | -187.6% | +217.7% | -4.9% | +71.5% | -82.6% | +185.8% | +93.0% | -14.6% | -91.0% | +985.0% | +82.9% | -18.0% | +3.1% |
| YoY Change | — | — | — | -140.5% | +221.0% | — | -582.7% | +621.9% | +18.1% | +68.1% | +133.4% | -18.9% | +64.6% | -18.0% | -57.4% | +61.8% | +53.3% | +47.2% | >999% |
Range-$103.30M – $291.80M
CAGR+38.2%
Avg YoY Growth+136.7%
Median YoY Growth+53.3%
Pre-Tax Income at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's pre-tax income?
- Neurocrine Biosciences (NBIX) reported pre-tax income of $246.80M in Q1 2026.
- How has Neurocrine Biosciences's pre-tax income changed year-over-year?
- Neurocrine Biosciences's pre-tax income increased by 1578.9% year-over-year, from $14.70M to $246.80M.
- What is the long-term trend for Neurocrine Biosciences's pre-tax income?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's pre-tax income has grown at a 48.8% compound annual growth rate (CAGR), from $213.90M to $705.40M.
- What does pre-tax income mean?
- Total profit earned before accounting for income tax obligations.